The prevalence of resistance to antituberculosis drugs in Riyadh was found to be 21.3%, while the rate of primary drug resistance was 11.5%. Resistance to isoniazid was the most common (19.4%) followed by rifampicin and streptomycin. The prevalence of primary and acquired rifampicin resistance was 3 and 33.7% respectively. The majority of isolates from patients with acquired resistance to rifampicin were resistant also to isoniazid.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0041-3879(89)90052-4 | DOI Listing |
Publication Analysis
Top Keywords
resistance antituberculosis
8
antituberculosis drugs
8
drugs riyadh
8
resistance
6
riyadh saudi
4
saudi arabia
4
arabia prevalence
4
prevalence resistance
4
riyadh 213%
4
213% rate
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!